← All trials
NCT04290390
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 12, 2020
- Primary completion
- Nov 21, 2020
- Completion date
- Jan 11, 2021
- First posted
- Feb 28, 2020
- Last posted
- Feb 28, 2020
- Enrollment
- 70
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- TherapeuticsMDLead sponsor
- TherapeuticsMDStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.